Corporate governance

Corporate Governance & Articles of Association

Neola Medical AB (publ) is a Swedish public limited company with its registered office in Lund. The company’s share is listed on the Nasdaq First North Growth Market in Stockholm under the short name GPXMED, more information about the share can be found in the menu on the left. Governance, management and control are distributed between the shareholders at the Annual General Meeting, the company’s board, the CEO, the Swedish Companies Act and the current Articles of Association.

Neola Medical AB (publ) does not follow the Swedish Code of Corporate Governance.

Board & Management

Neola Medical’s Board consists of five members elected at Neola Medical’s Annual General Meeting on May 20, 2021.

Märta Lewander Xu

Chairman of the Board since 2019, former CEO on a part-time basis and board member for Neola Medical 2016-2019.

Experience and education

Märta Lewander Xu has a doctorate in technology in physics, has a master’s degree in technical physics and a teaching degree in mathematics and physics. Märta was employed at Gasporox AB (publ) in 2010 as CTO and has been CEO of Gasporox AB (publ) since January 2015, which is listed on Nasdaq First North, board member of Lund Laser Center at Lund University, BeammWave AB, Serstech AB and Inscientia AB, and deputy board member of CxTx AB.
Märta Lewander Xu is independent in relation to the company and its management, independent in relation to the company’s major owners.

Number of shares held in the company

244,316 shares, 60,000 warrants issued within the framework of incentive program 2021/2025B.

Anders Weilandt

Board member since 2022.

Experience and education

Anders Weilandt, born 1961, is a Medical Electronics Engineer and holds an Executive MBA from Copenhagen Business School. Anders is the CEO of Chordate Medical AB (publ) and currently has a number of board assignments in various companies. He has previously been President of Ascendia MedTech AB, President of Diabetes Tools Sweden AB and Board member and CEO of Stille AB (publ). Anders has extensive experience of regulatory processes, CE marking and international expansion of new medical devices.

Anders Weilandt is independent in relation to the company and its management, dependent in relation to the company’s major owners.

Number of shares held in the company

0 shares.

Tommy Hedberg

Board member since 2022.

Experience and education

Tommy Hedberg, born 1955, has a Chemical Engineering degree followed by a post-secondary Economics degree. Tommy also has a medical LIF undergraduate degree from his time at Janssen Pharma. During the years 1998 – 2014, Tommy was CEO 2014–2016 and a board member at Atos Medical. He was also responsible for marketing and sales at Atos Medical 1990 – 1998. Before Tommy started working at Atos Medical, he worked as head of the medical technology division at Medscand with international marketing and sales. Prior to that, Tommy worked for 9 years in sales and marketing at Janssen Pharma.

Tommy Hedberg is independent in relation to the company and its management, independent in relation to the company’s major owners.

Number of shares held in the company

0 shares.

Mattias Lundin

Board member since 2022.

Experience and education

Mattias Lundin, born 1968, has a degree in Business Administration from IHM Business School in Stockholm and several international strategy and leadership training courses within the Sara Lee Corporation, the Getinge Group and IMD Lausanne. He now works as CEO of Lumito AB (publ) and has previously been Vice President Global Sales at CellaVision AB (publ) and held a number of senior positions within the Arjo Group (formerly Getinge), most recently as Vice President Commercial for International Mature Markets. Mattias has solid international experience in sales and marketing and is a team player with a strong track record when it comes to building successful teams for global expansion of new technology.

Mattias Lundin is independent in relation to the company and its management, independent in relation to the company’s major owners.

Number of shares held in the company

0 shares.

 

Urban Ottosson

Board member since 2021.

Experience and education

Urban Ottosson has a master’s degree in economics from Lund University and a degree from KTH Executive School in Stockholm. He has worked as CFO since 1999 in several companies, including HEXPOL, Beijer Electronics, Höganäs Group, Öresundskraft and Lammhults Design Group. He is also a private investor in addition to his assignments. Former board member of Lendify AB and chairman of the board of Modity Energy Trading. He was CFO of Neola Medical 2020-2021. He is the CEO and board member of Predictus Asset Management AB, and CFO of TePe Munhygienprodukter.

Urban Ottosson is independent in relation to the company and its management, independent in relation to the company’s major owners

Number of shares held in the company

156,250 shares via Predictus Asset Management AB, 100,000 warrants issued within the framework of the Incentive Program 2021/2025A.

Neola Medical management & team

Neola Medical’s management consists of CEO Hanna Sjöström and CFO Christian Gyllenberg. In addition to the management, there is a strong team of key people with both technical and medical expertise. The team is also complemented by an extensive network of specialist consultants.

Hanna Sjöström

External CEO since 2019.

Experience and education

Hanna Sjöström has a master’s degree in economics from Lund University (Master of Business Administration) with a specialization in Technology Management. She has also taken a course in leadership in the Executive MBA program of the Swedish Management Group, and is a certified board member in Life Sciences. Hanna has held leading positions in large groups such as L’Oréal, the Coca-Cola Company and a senior position at TePe Munhygiensproduker AB, where she was part of the company’s management team. Hanna is also chairman of the board of Inscientia AB.

Number of shares held in the company

265,276 shares, 200,000 warrants issued within the framework of the Incentive Program 2021/2025A.

Christian Gyllenberg

CFO since 2022.

Experience and education

Christian Gyllenberg has a bachelor’s degree in Business Law and a bachelor’s degree in Business Administration from Kristianstad University. He has previously worked with auditing and as a Business Controller in business-related roles at companies in various industries such as EY, Attendo and DHL. He is the CFO of Aurora Punks alongside his assignment at Neola Medical.

Number of shares held in the company

0 shares.